NEW YORK, June 30, 2020 /PRNewswire/ — TrialJectory, an AI-powered know-how platform that matches cancer patients with personalised superior remedy choices, introduced at the moment the supply of PRA Health Sciences‘ Health Concord COVID-19 Monitoring Program for its international neighborhood of oncology patients. Entry to this free program via the Health Concord cell app permits patients to monitor and report COVID-related symptoms from the consolation of their very own houses to their healthcare suppliers for rapid response.
The COVID-19 pandemic has had an instantaneous, devastating impression on cancer patients’ day by day lives. Apart from being one of many highest-risk populations due to patients’ already compromised immune programs, cancer patients are additionally experiencing overburdened healthcare programs, ensuing in the delay or cancellation of oncology remedy plans and required testing. Because the U.S. begins a phased reopening, cancer patients should be much more vigilant about monitoring and stopping publicity to the virus.
Since March, hundreds of customers have downloaded the Health Concord app and enrolled in the COVID-19 Monitoring Program via their employer, suppliers and healthcare networks. As a part of this system, customers can observe their very own COVID-19 symptoms and educate themselves in regards to the disease. The COVID-19 Monitoring Program gives three ranges of help to TrialJectory members, based mostly on their private state of affairs:
- The academic program, which offers important signal monitoring, prevention methods and mental health help for those that are asymptomatic.
- The quarantine program, which delivers insights on what to watch for, addresses emotions of worry and isolation, and connects with a healthcare skilled for those that have been uncovered to COVID-19.
- The in-depth monitoring program, which addresses symptom administration, frequent monitoring by a healthcare skilled and care coordination for those that have examined constructive for COVID-19 and who’re nonetheless at house.
Quick, easy accessibility to symptom monitoring and skilled healthcare staff who can be found to reply COVID questions will likely be important throughout this time when disease transmission continues to be excessive, and a vaccine just isn’t but accessible. Leveraging real-world knowledge and cutting-edge cell know-how, TrialJectory’s partnership with PRA additional highlights each firms’ ongoing dedication to empowering cancer patients to take possession of their private healthcare journey.
“The Health Concord COVID-19 program and its capability to observe patient symptoms is a real-life instance of how telehealth and cell monitoring are rapidly changing into the brand new commonplace of care in at the moment’s pandemic setting,” stated Kent Thoelke, Govt Vice President and Chief Scientific Officer, PRA Health Sciences. “The collaboration between our team at Care Improvements and TrialJectory brings that very same know-how straight into the palms of cancer patients throughout the U.S. and delivers larger healthcare entry to individuals who want it essentially the most.”
“Because the outbreak, we’ve got seen a major enhance in patient conversations inside our neighborhood about how to stop patients from contracting and spreading COVID-19,” added Tzvia Bader, CEO and co-founder, TrialJectory. “It is vital – and even lifesaving – that cancer patients study as a lot as they’ll in regards to the virus, perceive prevention methods and rapidly get their questions answered by certified healthcare professionals who’re devoted particularly to this effort. Giving this instrument to cancer patients brings us one step nearer to making this a actuality, permitting patients to stay absolutely knowledgeable, healthy and secure till the pandemic passes for good.”
Cancer patients and their households want to stay vigilant when monitoring for the symptoms of COVID-19. With this disease persevering with to unfold at a high-rate of pace in the US, the Health Concord cell app gives real-time entry to biometric monitoring, academic supplies and skilled healthcare professionals – proper on the patients’ fingertips.
“Monitoring for Coronavirus symptoms utilizing the app has given me again a way of management that was fully misplaced as somebody dwelling with the danger of cancer recurrence throughout this pandemic,” stated Alin Wagner-Lahmy, a breast cancer survivor and mom of two. “Having one supply of data that I can depend on to be essentially the most correct, a way to observe my well being from day to day, and the flexibility to communicate straight to an actual individual, has actually helped to calm my nervousness.”
To study extra, please go to: https://www.trialjectory.com/covid-19-monitoring/
About TrialJectory
TrialJectory is an AI-powered choice help platform that democratizes entry to superior remedy info. TrialJectory AI know-how matches patients with personalised superior remedy choices immediately, and offers them with skilled help all through their cancer journey. TrialJectory additionally analyzes the patient neighborhood’s real-world knowledge of therapies and outcomes enabling all cancer patients to obtain the perfect of care. www.trialjectory.com.
About PRA Health Sciences
PRA Health Sciences is without doubt one of the world’s main international contract research organizations by income, offering outsourced medical improvement and knowledge resolution companies to the biotechnology and pharmaceutical industries. PRA’s international medical improvement platform consists of greater than 75 workplaces throughout North America, Europe, Asia, Latin America, South Africa, Australia and the Center East and greater than 17,500 staff worldwide. Since 2000, PRA has participated in roughly 4,000 medical trials worldwide. As well as, PRA has participated in the pivotal or supportive trials that led to U.S. Meals and Drug Administration or worldwide regulatory approval of greater than 95 medication. To study extra about PRA, please go to www.prahs.com.
View authentic content material:http://www.prnewswire.com/news-releases/trialjectory-and-pra-health-sciences-team-up-to-assist-cancer-patients-in-monitoring-for-covid-19-symptoms-301085374.html
SOURCE TrialJectory
Leave a Reply